<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347027</id>
  <title nil="true"/>
  <common-name>2-[4-[[1-[3-(4-methylphenyl)-3-oxopropyl]benzimidazol-2-yl]methyl]piperazin-1-yl]-n-propan-2-ylacetamide</common-name>
  <description>2-[4-[[1-[3-(4-methylphenyl)-3-oxopropyl]benzimidazol-2-yl]methyl]piperazin-1-yl]-n-propan-2-ylacetamide is a compound with the formula C27H35N5O2. It has an average molecular weight of 461.60 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>3045585</pubchem-id>
  <chemical-formula>C27H35N5O2</chemical-formula>
  <weight>461.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T10:39:00Z</created-at>
  <updated-at type="dateTime">2026-08-31T10:39:00Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)C(=O)CCN2C3=CC=CC=C3N=C2CN4CCN(CC4)CC(=O)NC(C)C</moldb-smiles>
  <moldb-formula>C27H35N5O2</moldb-formula>
  <moldb-inchi>InChI=1S/C27H35N5O2/c1-20(2)28-27(34)19-31-16-14-30(15-17-31)18-26-29-23-6-4-5-7-24(23)32(26)13-12-25(33)22-10-8-21(3)9-11-22/h4-11,20H,12-19H2,1-3H3,(H,28,34)</moldb-inchi>
  <moldb-inchikey>GGRWCBAXEGASLW-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">461.2790754</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342920</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[4-[[1-[3-(4-methylphenyl)-3-oxopropyl]benzimidazol-2-yl]methyl]piperazin-1-yl]-n-propan-2-ylacetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbonyl compounds</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0297375</sync-id>
  <structure-inchikey>GGRWCBAXEGASLW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000004400000020800000000400000000000000000000000000001000000000041040000002000000000400002000000000000000000000400000000000100000000000000000000000000000000020000000000000000000000000000000018000210000000000000000000000000000020100000100000000000000000801000040008000804000000000004080000000000100000000000000000000040000008000000000000000084000080000000000100000008000000000000000000408000000000000200000000000000000044000002000000200040000010000020100000001000040000000008480000000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:37Z</structure-indexed-at>
</compound>
